[1] |
POTTS J, SIRKER A, MARTINEZ S C,et al. Persistent sex disparities in clinical outcomes with percutaneous coronary intervention:insights from 6.6 million PCI procedures in the United States[J]. PLoS One, 2018, 13(9):e0203325. DOI: 10.1371/journal.pone.0203325.
|
[2] |
SAVONITTO S, COLOMBO D, FRANCO N,et al. Age at menopause and extent of coronary artery disease among postmenopausal women with acute coronary syndromes[J]. Am J Med, 2016, 129(11):1205-1212. DOI: 10.1016/j.amjmed.2016.05.031.
|
[3] |
DAMA, BAGGIO C, BOSCARO C,et al. Estrogen receptor functions and pathways at the vascular immune interface[J]. Int J Mol Sci, 2021, 22(8):4254. DOI: 10.3390/ijms22084254.
|
[4] |
KRATOFIL R M, KUBES P, DENISET J F. Monocyte conversion during inflammation and injury[J]. Arterioscler Thromb Vasc Biol, 2017, 37(1):35-42. DOI: 10.1161/ATVBAHA.116.308198.
|
[5] |
LI Q X, MA X T, SHAO Q Y,et al. Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients[J]. Front Cardiovasc Med, 2022, 9:811790. DOI: 10.3389/fcvm.2022.811790.
|
[6] |
KARATAŞ M B, ÇANGA Y, ÖZCAN K S,et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention[J]. Am J Emerg Med, 2016, 34(2):240-244. DOI: 10.1016/j.ajem.2015.10.049.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
DEGER M, OZMEN C, AKDOGAN N,et al. The relationship between gensini score and erectile dysfunction in patients with chronic coronary syndrome[J]. Sex Med, 2021, 9(3):100376. DOI: 10.1016/j.esxm.2021.100376.
|
[12] |
SALTIKI K, DOUKAS C, KANAKAKIS J,et al. Severity of cardiovascular disease in women:relation with exposure to endogenous estrogen[J]. Maturitas, 2006, 55(1):51-57. DOI: 10.1016/j.maturitas.2005.12.008.
|
[13] |
GÜRDOĞAN M, ALTAY S, KORKMAZ S,et al. The effect of thyroid stimulating hormone level within the reference range on in-hospital and short-term prognosis in acute coronary syndrome patients[J]. Medicina, 2019, 55(5):175. DOI: 10.3390/medicina55050175.
|
[14] |
SUN Y, TENG D, ZHAO L,et al. Impaired sensitivity to thyroid hormones is associated with hyperuricemia,obesity,and cardiovascular disease risk in subjects with subclinical hypothyroidism[J]. Thyroid, 2022, 32(4):376-384. DOI: 10.1089/thy.2021.0500.
|
[15] |
ZHANG J M, WU H X, MA S Z,et al. TSH promotes adiposity by inhibiting the browning of white fat[J]. Adipocyte, 2020, 9(1):264-278. DOI: 10.1080/21623945.2020.1783101.
|
[16] |
LI J X, KONG D X, GAO X Y,et al. TSH attenuates fatty acid oxidation in hepatocytes by reducing the mitochondrial distribution of miR-449a/449b-5p/5194[J]. Mol Cell Endocrinol, 2021, 530:111280. DOI: 10.1016/j.mce.2021.111280.
|
[17] |
SU X, PENG H, CHEN X,et al. Hyperlipidemia and hypothyroidism[J]. Clin Chim Acta, 2022, 527:61-70. DOI: 10.1016/j.cca.2022.01.006.
|
[18] |
DELITALA A P, SCUTERI A, FIORILLO E,et al. Role of adipokines in the association between thyroid hormone and components of the metabolic syndrome[J]. J Clin Med, 2019, 8(6):764. DOI: 10.3390/jcm8060764.
|
[19] |
BREATHETT K, SIMS M, GROSS M,et al. Cardiovascular health in American indians and Alaska natives:a scientific statement from the American heart association[J]. Circulation, 2020, 141(25):e948-959. DOI: 10.1161/CIR.0000000000000773.
|
[20] |
SHIFFLER J A, GOERGER K A, GORRES-MARTENS B K. Estrogen receptor α activation modulates the gut microbiome and type 2 diabetes risk factors[J]. Physiol Rep, 2022, 10(11):e15344. DOI: 10.14814/phy2.15344.
|
[21] |
HODIS H N, MACK W J. Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease:it is about time and timing[J]. Cancer J, 2022, 28(3):208-223. DOI: 10.1097/PPO.0000000000000591.
|
[22] |
KOENIG W. Low-grade inflammation modifies cardiovascular risk even at very low LDL-C levels:are we aiming for a dual target concept?[J]. Circulation, 2018, 138(2):150-153. DOI: 10.1161/CIRCULATIONAHA.118.035107.
|
[23] |
BJÖRNSTRÖM L, SJÖBERG M. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions[J]. Mol Endocrinol, 2002, 16(10):2202-2214. DOI: 10.1210/me.2002-0072.
|
[24] |
BAJPAI G, BREDEMEYER A, LI W J,et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury[J]. Circ Res, 2019, 124(2):263-278. DOI: 10.1161/CIRCRESAHA.118.314028.
|
[25] |
GHATTAS A, GRIFFITHS H R, DEVITT A,et al. Monocytes in coronary artery disease and atherosclerosis:where are we now?[J]. J Am Coll Cardiol, 2013, 62(17):1541-1551. DOI: 10.1016/j.jacc.2013.07.043.
|
[26] |
LIU M P, LIU X J, WEI Z,et al. MHR and NHR but not LHR were associated with coronary artery disease in patients with chest pain with controlled LDL-C[J]. J Investig Med, 2022, 70(7):1501-1507. DOI: 10.1136/jim-2021-002314.
|
[27] |
CETIN M S, OZCAN CETIN E H, KALENDER E,et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J]. Heart Lung Circ, 2016, 25(11):1077-1086. DOI: 10.1016/j.hlc.2016.02.023.
|
[28] |
KIM K W, IVANOV S, WILLIAMS J W. Monocyte recruitment,specification,and function in atherosclerosis[J]. Cells, 2020, 10(1):15. DOI: 10.3390/cells10010015.
|
[29] |
NAZIR S, JANKOWSKI V, BENDER G,et al. Interaction between high-density lipoproteins and inflammation:function matters more than concentration![J]. Adv Drug Deliv Rev, 2020, 159:94-119. DOI: 10.1016/j.addr.2020.10.006.
|
[30] |
|